Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-23

Clinical Trial Update: Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2) [Phase 2]

View source ↗

Summary

Phase 2 study investigating whether acyclovir can suppress HIV viral load in women co-infected with HIV and HSV-2. The trial has completed; the brief snippet do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACYCLOVIR (Acyclovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Herpesvirus 2, Human | Phase 2 | Status: COMPLETED